Collectively, these results demonstrated that astragalus administration could be a potential treatment for DN, and that astragalus could ameliorate the outcomes associated with DN by hindering the TGFβ/Smad pathway. This evidence concerns the gene TGFB1 and liver dysplastic nodule.